Amrutanjan Health Care Intrinsic Value
Amrutanjan Health Care intrinsic value. Amrutanjan Health Care (AMRUTANJAN) median intrinsic value is ₹726.67 from 3 valuation models (range ₹196–₹951), vs current price ₹518.10 — +40.3% upside (Trading Below Calculated Value), margin of safety 28.7%. Compare with Amrutanjan Health Care value estimation to assess whether the stock is under or overvalued.
AMRUTANJAN Valuation Methods Summary — DCF, Graham Number & P/E
Amrutanjan Health Care intrinsic value across 3 models vs current price ₹518.10 — upside/downside and value range per method. Read AMRUTANJAN dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹726.67 | ₹654.00 - ₹799.34 | +40.3% | Book Value/Share: ₹363.33, P/B: 2.0x |
| Simple DCF (5Y) | dcf | ₹950.83 | ₹760.66 - ₹1141.00 | +83.5% | CF Growth: 15.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹196.00 | ₹176.40 - ₹215.60 | -62.2% | DPS: ₹4.90, Target Yield: 2.5% |
AMRUTANJAN Intrinsic Value vs Market Price — All Valuation Models
Amrutanjan Health Care fair value range ₹196–₹951 vs current market price ₹518.10 across 3 valuation models. For current market price and key ratios, visit Amrutanjan Health Care share price screener.
AMRUTANJAN Intrinsic Value Analysis — Undervalued or Overvalued?
Amrutanjan Health Care median intrinsic value ₹726.67, current price ₹518.10 — Trading Below Calculated Value by 40.3%, margin of safety 28.7%.
What is the intrinsic value of AMRUTANJAN?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Amrutanjan Health Care (AMRUTANJAN) is ₹726.67 (median value). With the current market price of ₹518.10, this represents a +40.3% variance from our estimated fair value.
The valuation range spans from ₹196.00 to ₹950.83, indicating ₹196.00 - ₹950.83.
Is AMRUTANJAN undervalued or overvalued?
Based on our multi-method analysis, Amrutanjan Health Care (AMRUTANJAN) appears to be trading below calculated value by approximately 40.3%.
AMRUTANJAN Financial Health — Key Ratios vs Industry Benchmarks
Amrutanjan Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 25.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
AMRUTANJAN Cash Flow Quality — Operating & Free Cash Flow
Amrutanjan Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2016 | ₹21 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2015 | ₹18 Cr | ₹16 Cr | Positive Free Cash Flow | 8/10 |